Medtech’s hottest topics in M&A, intellectual property, finance and regulation will be on the agenda at DeviceTalks Boston Oct. 8-11. Patent attorney David Dykeman from the Boston office of the global law firm Greenberg Traurig will moderate the Oct. 9 hot topics panel in which the discussion will center around: · M&A trends from the perspective of […]
LuxCath eyes the atrial fibrillation market
One problem with using ablation to treat atrial fibrillation is determining when the resulting lesion is sufficient to block the electric signals underlying the arrhythmia. LuxCath thinks its OmniView catheter solves the dilemma by using an optical technology to assess metabolic activity in the ablated tissue, CEO Dr. Omar Amirana told MassDevice.com earlier this month […]
Mergers, IP, risk assessment among trends in medtech
In 1995, the average time to a successful exit for a medical device startup was about 3 years, according to Rotational Medical CEO Martha Shadan. Now, Shadan said, it can range from 6 to 9 years and cost as much as $50 million. Shadan suggested that the increase in exit time is probably due to […]
GE’s venture arm, Allied Minds join forces
GE Healthcare‘s (NYSE:GE) Venture arm said today it signed a strategic alliance with Boston-based innovation development group Allied Minds to develop and commercialize “next-generation technologies.” Through the deal, GE and Allied Minds will invest in both new and existing tech sourced from both company’s pipelines, both existing and new. Allied Minds will recive exclusive right of […]
HistoSonics pulls in $14M | Medtech funding for the week of May 19, 2014
Allied Minds prepares $140M U.K. IPO to support U.S. R&D
Boston-based innovation development group Allied Minds is planning a $140 million (£83 million) initial public offering on the London Stock Exchange in support of its effort to commercialize products in the U.S.
Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat
Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.
Allied Minds forms med-tech focused subsidiary
Boston-based technology commercialization firm Allied Minds Inc. launched a new subsidiary addressing medical devices, the company announced today.
The newly formed Allied Minds Devices LLC will focus its efforts on developing medical devices originating from U.S. universities and federally funded research institutions.
Omar Amirana leaves Oxford for Allied Mind | Personnel Moves
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Venture Capital: Omar Amirana leaves Oxford for Allied Minds
Amirana
Omar Amirana, a partner at Oxford Biosciences, a life sciences VC firm that manages more than $1 billion in capital, will be pulling up anchor and moving over to Allied Minds, a “a private equity-funded innovation company.”
Allied Minds, which bills itself as “a holding company that creates subsidiary companies and supports them with capital, management, and shared services,” has offices in Boston and Los Angeles. The firm has over $250 million in assets and specializes in developing technology created at universities and research labs.
